| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |